卵巢癌的篩檢

Ovarian Cancer Screening

現階段卵巢癌的篩檢，多在停經後婦女，以陰道超音波和和血清的CA125同時來篩檢，但只得到部份效果。因卵巢癌的婦女發生率不高，約2500位婦女有1位罹病，低發生率是造成卵巢癌篩檢難以突破最大原因。但是，如患者有腹部或骨盆腔疼痛、腹圍增加、胃脹氣、疲倦、消化不良、無法正常進食、頻尿、便秘、背痛、近期小便失禁、或無法解釋的體重下降，仍應做陰道超音波和CA125來篩檢卵巢癌的可能性。

Both transvaginal ultrasonography and the serum biomarker CA125 have been used to screen for early ovarian cancer. Studies to date, however, have not demonstrated a clear effect of screening with transvaginal ultrasonography or CA125 on mortality from ovarian cancer. The prevalence of ovarian cancer in the normal postmenopausal population is about 1 in 2500. The low prevalence of the disease is the enemy of any reliable screening test for ovarian cancer. However, flank pain, abdominal bloating and pain, loss of appetite and fullness, and a variety of other abdominal, gastrointestinalm and urinary tract symptoms were recorded in significantly more women who were diagnosed with ovarian cancer cancer than in the control subjects. Therefore, there were to recommend evaluation of these signs and symptoms of ovarian cancer.